For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials

For The First Time Ever, A Drug Developed By AI Will Be Tested In Human Trials

Publication date: Feb 11, 2020

In a world first, a medicine developed by artificial intelligence may be used to treat patients with obsessive-compulsive disorder. The news is remarkable and hints that in the future, AI may help drug development become faster and more efficiently than ever before.

Concepts Keywords
Artificial Intelligence
Obsessive Compulsive Disorder

Semantics

Type Source Name
disease MESH development
disease MESH obsessive-compulsive disorder

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *